Showing 1 to 4 of 4 Clinical Trials
|
CLINICAL TRIAL Trial No ClinicalTrials.gov ID |
Principal Investigator
Coordinator |
||
|---|---|---|---|
|
Lymph node oesophagus cancer
CT0075 n.d.  Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Oesophagus |
Dr. Moishe Liberman Adeline Jouquan 514-890-8000 poste 26214 |
|
A Randomized, Multi-center, Double-blind, Placebo-controlled Phase 3 Study of Bemarituzumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Subjects With Previously Untreated Advanced Gastric or Gastroesophageal Junction Cancer With FGFR2b Overexpression
FORTITUDE-101 NCT05052801 Recruiting
|
CIUSSS DU CENTRE-OUEST-DE-L'ILE-DE-MONTREAL
HOPITAL GENERAL JUIF SIR MORTIMER B.DAVIS
|
Oesophagus Stomach |
Dr. Petr Kavan Aline Mamo 514-340-8222 poste 5525 |
|
A Phase 1b/3 Study of Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab Alone in Subjects With Previously Untreated Advanced Gastric and Gastroesophageal Junction Cancer With FGFR2b Overexpression
FORTITUDE-102 NCT05111626 Recruiting
|
CHU DE QUEBEC – UNIVERSITE LAVAL
L'HOTEL-DIEU DE QUEBEC ET CRCEO
|
Oesophagus Stomach |
Dr. Maxime Chénard-Poirier Maryse Gingras 418-691-5781 |
|
A Randomized Phase II Study of Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Positive Advanced Gastroesophageal Adenocarcinoma
CCTG GA4 NCT06043427 Recruiting
|
CENTRE HOSPITALIER DE L'UNIVERSITE DE MONTREAL
|
Oesophagus Stomach |
Dr. Mustapha Tehfé Chantal Gosselin 514-890-8000 poste 24892 |
Groupe d'étude en oncologie du Québec